About Omada Health
Omada Health is a digital behavioral medicine company that helps people to change the habits that put them most at risk for serious but largely preventable chronic conditions like heart disease and type 2 diabetes. The company brings behavioral counseling to anyone with an Internet connection, using insights about social networking, gaming, and behavioral science to motivate changes in lifestyle and deliver clinically-meaningful results.
ESPs containing Omada Health
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The companies in this market use virtual care technology to provide care remotely to patients. These companies offer virtual primary care and other specialized care visits for elders that require preventative health checks, chronic condition treatments, and more.
Compete with Omada Health?
Ensure that your company and products are accurately represented on our platform.
Omada Health's Products & Differentiators
User-friendly mobile and desktop application
Our user-friendly mobile and desktop application provides integrated care pathways across five chronic conditions to address these critical conditions and their comorbidities. Data-driven interventions to improve health and support lasting change Behavior change + clinical guidelines delivered at scale Personalized treatment plans Dedicated care teams to support members’ changing needs Interactive condition-specific content Social support from dedicated peer groups and topic-based communities Goal-setting and goal feedback from a member’s care team Easy self-monitoring through condition-specific connected devices Cross-program referrals Physician-guided care through telemedicine capabilities.
Research containing Omada Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Omada Health in 21 CB Insights research briefs, most recently on Oct 28, 2022.
Expert Collections containing Omada Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Omada Health is included in 11 Expert Collections, including Digital Health.
Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)
Unicorns- Billion Dollar Startups
Digital Health 150
2019's cohort of the most promising digital health startups transforming the healthcare industry
Tech IPO Pipeline
Track and capture company information and workflow.
Future Unicorns 2019
Omada Health Patents
Omada Health has filed 1 patent.
Diabetes, Obesity, Nutrition, Diets, Cytokines
Diabetes, Obesity, Nutrition, Diets, Cytokines
Latest Omada Health News
Nov 16, 2022
News provided by Share this article Report Scope: The current report covers the booming technology of digital therapeutics.It also investigates the current shift in trends away from conventional methods of treatment toward the advanced means offered by digital therapeutics. This report is an update of an earlier report of the same title but focuses on more in-depth information.This report offers a comprehensive analysis of the global digital therapeutics market. Segmentation is based on application and sales channels.Based on application, the market is segmented as diabetes, psychiatric and addiction, neurological, cardiovascular diseases, and others. Based on sales channel the market is segmented as business-to-consumer (B2C) and business-to-business (B2B). The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2019, 2020, and 2021 as the base year, 2022, and a forecast for 2027. The report provides a detailed overview and analysis of the present and future global market for digital therapeutics.Industry growth drivers, restraints, and opportunities are also discussed in detail. The report also provides a competitive landscape, elaborative company profiles, and the impact of COVID-19 on the market. The report focuses on the companies that are developing and encouraging digital therapeutics technology and doing research to develop the technology further. Report Includes: - A brief general outlook of the global market for digital therapeutics scenario - Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027 - Highlights of the current and upcoming market potential for digital therapeutics, and areas of focus to forecast this market into various segments and subsegments - Updated information on market opportunities and drivers, key shifts and trends, regulations and industry specific challenges, and other factors that will shape this market demand in the coming years (2022-2027) - Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages - Review of the technology landscape for digital therapeutics marketplace with emphasis on recently approved products as well as products under development or in different stages of clinical trials - Profile descriptions of the market leading participants, including Big Health, Happify, Omada Health Inc., Pear Therapeutics and Welldoc Summary: Digital therapeutics (DTx) is considered a subset of digital health.These are evidence-based, innovative interventions in which the therapeutic activity is based on algorithms and software. These interventions can be a standalone treatment or used in combination with the current medications. Digital therapeutics are highly customizable tools and hence the growing demand for personalized and preventive treatment will be a driving factor for the market.The tool allows better involvement of the patient in the management of the disease. Thus, this technology provides an opportunity to cater to the chronic diseases segment. Chronic diseases create a significant burden on the healthcare system in terms of morbidity and finances.Since the majority are lifestyle-related disorders, modifications in lifestyle will help to prevent or reduce the burden of the diseases. An example of this is prediabetes prevention, where DTx tools will help to prevent or delay the diagnosis of the disease.DTx also provides digital cognitive behavioral therapies (CBT), which are required for psychiatric indications such as post-traumatic stress disorder (PTSD), attention-deficit/hyperactivity disorder (ADHD), and depression. Due to the pandemic, the prevalence of these psychiatric disorders has also increased. Thus, the increasing prevalence of chronic conditions and the increasing burden of the healthcare system will lead to increased adoption of digital solutions. Compared to traditional drug development, the cost of developing digital therapeutics is relatively low. The other factors contributing to the growth of the market include increasing investment in digital health and digital therapeutics, growing research activities, and the increasing use of smartphones, mhealth apps, and wearables.It is observed that initially only academic and tech companies were involved in the development and research of digital therapeutics. But the increasing investments in this space have attracted a number of pharma and other players in the market. The market has a number of small players and start-up companies and is expected to witness the entry of other players in the future, as many companies have ongoing pivotal trials in their portfolio. Since this market is in its nascent stage, there is a lack of regulatory and reimbursement guidelines. Hence, developing proper regulatory and reimbursement frameworks will attract more users to the market. The global market for digital therapeutics was estimated to be $REDACTED billion in 2021, and the market is expected to increase to nearly $REDACTED billion through 2027, growing at a compound annual growth rate (CAGR) of REDACTED% during the forecast period. Players in the market include Pear Therapeutics, Click Therapeutics, Akili Interactive, Omada Health, Big Health, Voluntis, Propeller, and others. In this report, the market is segmented based on application, sales channel, and region.The North American market currently holds the highest market share, followed by Europe. This leadership role is due to the increasing prevalence of chronic diseases in the U.S., increasing investments, rising demand for cost-effective and patient-centric solutions, and increasing awareness.
Omada Health Web Traffic
Omada Health Rank
Omada Health Frequently Asked Questions (FAQ)
When was Omada Health founded?
Omada Health was founded in 2011.
Where is Omada Health's headquarters?
Omada Health's headquarters is located at 500 Sansome Street, San Francisco.
What is Omada Health's latest funding round?
Omada Health's latest funding round is Series E.
How much did Omada Health raise?
Omada Health raised a total of $449.72M.
Who are the investors of Omada Health?
Investors of Omada Health include dRx Capital, Civilization Ventures, Wellington Management, Perceptive Advisors, aMoon Fund and 27 more.
Who are Omada Health's competitors?
Competitors of Omada Health include BeatO, Ciba Health, January, Fitterfly, Zhiyun Health, PeerWell, Sidekick Health, ZealCare, 9am.health, DIABNEXT and 60 more.
What products does Omada Health offer?
Omada Health's products include User-friendly mobile and desktop application and 4 more.
Who are Omada Health's customers?
Customers of Omada Health include Cigna.
Compare Omada Health to Competitors
Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. Glooko's systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.
WellDoc is a healthcare behavioral science and technology company that focuses on simplifying the way chronic diseases are managed through a collaborative approach that breaks down the barriers of engagement and adherence by providing patients and healthcare providers with real-time information. WellDoc has developed a technology-based solution designed to help people with chronic diseases better manage conditions. The flagship product, DiabetesManager, provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence.
One Drop is a consumer digital health company that has developed One Drop. Available for download for iOS and Apple Watch, One Drop harnesses the power of mobile computing and data science to empower people with diabetes to live healthier lives.
Virta Health develops a clinically-proven treatment to safely and sustainably reverse type 2 diabetes and other chronic metabolic diseases without the use of medications or surgery.
Vida Health is a virtual care company that combines a human-centric approach with technology to address chronic physical and behavioral health conditions. The company provides personalized digital therapeutic programs combined with real human health coaching & therapy through a mobile & online platform that supports individuals in managing & reversing conditions such as diabetes, hypertension, obesity, depression, anxiety, stress, asthma, & more. The platform integrates individual expert care with machine learning & remote monitoring to deliver lasting behavior change, health outcomes & cost savings.
Lark Health is a virtual chronic disease management and prevention platform. Lark helps people stay healthy and in control of their conditions, such as Diabetes, Prediabetes, Cardiovascular Disease, and Anxiety from the comfort of their homes.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.